|
C6ORF150 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.995830E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.020200E-01 |
| Normal-vs-Stage2 |
4.204400E-01 |
| Normal-vs-Stage3 |
1.304430E-01 |
| Normal-vs-Stage4 |
9.360600E-01 |
| Stage1-vs-Stage2 |
7.418000E-01 |
| Stage1-vs-Stage3 |
1.817840E-01 |
| Stage1-vs-Stage4 |
8.272200E-01 |
| Stage2-vs-Stage3 |
4.548800E-01 |
| Stage2-vs-Stage4 |
7.239200E-01 |
| Stage3-vs-Stage4 |
3.833000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.639000E-01 |
| Normal-vs-AfricanAmerican |
5.195400E-01 |
| Normal-vs-Asian |
5.980400E-01 |
| Caucasian-vs-AfricanAmerican |
7.855000E-01 |
| Caucasian-vs-Asian |
6.378800E-01 |
| AfricanAmerican-vs-Asian |
5.473600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.690400E-01 |
| Normal-vs-Female |
2.390800E-01 |
| Male-vs-Female |
6.507600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.057600E-01 |
| Normal-vs-Extreme_Weight |
8.276400E-01 |
| Normal-vs-Obese |
8.600000E-02 |
| Normal-vs-Extreme_Obese |
1.784840E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.557840E-01 |
| Normal_Weight-vs-Obese |
7.796500E-03 |
| Normal_Weight-vs-Extreme_Obese |
5.736800E-01 |
| Extreme_Weight-vs-Obese |
9.156200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.778640E-01 |
| Obese-vs-Extreme_Obese |
1.293610E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.453200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.259400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.713600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.761400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.050600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.856600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.726200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.710600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.716100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.063960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.698800E-01 |
| Normal-VS-Type2 PRCC |
4.051000E-01 |
| Normal-VS-KIRP CIMP |
3.881200E-03 |
| Normal-VS-Unclassified PRCC |
2.664000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.882600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.818480E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.224400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.594500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.015700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.163700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.775800E-01 |
| Normal-vs-N1 |
1.067560E-01 |
| Normal-vs-N2 |
3.774800E-01 |
| N0-vs-N1 |
1.160830E-01 |
| N0-vs-N2 |
4.554800E-01 |
| N1-vs-N2 |
6.840600E-01 |
|
|
